1-3 of 3
Valkal Bhatt, PharmD, BCOP, BCPS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outpatient BEAM Using Daily Etoposide and Cytarabine with Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Is Feasible and Decreases Inpatient Length of Stay

Naomi Cazeau, Kathleen Cavalier, NP, Valkal Bhatt, PharmD, BCOP, BCPS, Courtney McElrath, NP, Nicole Lestrange, NP, Margot Lachaud-Richard, MPA, Faye Inumerables, MSN, Marci Andrejko, NP, Jason Batalha, NP, Abigail Cohen, NP, Melissa Cortes, NP, Christina Kiss, NP, Dayna Palumbo, NP, Heather J Landau, MD, Oscar B Lahoud, MD, Parastoo B. Dahi, MD, Michael Scordo, MD, Craig S. Sauter, MD, Sergio A. Giralt, MD, Gunjan L. Shah, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5830.
https://doi.org/10.1182/blood-2019-127402
Published: 2019
Journal Articles

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on Close Haplo-Winning CB Unit HLA-Match

Ioannis Politikos, MD, Sean M Devlin, PhD, Christopher Mazis, BS, Molly Maloy, MS, Kristine Naputo, BA, Aishat Olaide Afuye, BA, Valkal Bhatt, PharmD, BCOP, BCPS, Andromachi Scaradavou, MD, Richard J. O'Reilly, MD, Scott T Avecilla, MD PhD, Hugo R. Castro-Malaspina, MD, Christina Cho, MD, Parastoo B. Dahi, MD, Sergio Giralt, MD, Boglarka Gyurkocza, MD, Katharine C. Hsu, MD PhD, Ann A. Jakubowski, MD PhD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Craig S. Sauter, MD, Michael Scordo, MD, Brian C. Shaffer, MD, Gunjan L. Shah, MD, Roni Tamari, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Doris Ponce, MD, Juliet Barker, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 2078.
https://doi.org/10.1182/blood-2018-99-116276
Published: 2018
Journal Articles

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

Jeremy Pappacena, PharmD, Valkal Bhatt, PharmD, BCOP, BCPS, Gunjan L. Shah, MD, Patrick Hilden, MS, Molly Maloy, MS, Larry W Buie, PharmD, BCOP, FASHP, Sergio A. Giralt, MD, Michael Scordo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1950.
https://doi.org/10.1182/blood.V130.Suppl_1.1950.1950
Published: 2017